空間ゲノミクスおよびトランスクリプトミクス市場 – 2029年までの世界予測

Report Overview

The spatial genomics & transcriptomics product market is expected to reach USD 995.7 million in 2029 from USD 554.5 million in 2024, at a CAGR of 12.4% during the forecast period.

空間ゲノミクスおよびトランスクリプトミクス製品市場は、予測期間中に12.4%のCAGRで、2024年の5億5,450万米ドルから2029年には9億9,570万米ドルに達すると予想されます。

The spatial genomics and transcriptomics market is expanding under the influence of factors like new product introduction and rising acceptance of spatial genomics and transcriptomics in medication discovery and development. Nevertheless, expensive initial capital inputs and technical complexity and knowledge gap create various difficulties for the industry.

空間ゲノミクスおよびトランスクリプトミクスの市場は、新製品の導入や医薬品の発見と開発における空間ゲノミクスおよびトランスクリプトミクスの受け入れの高まりなどの影響を受けて拡大しています。それにもかかわらず、高価な初期資本投入、技術的な複雑さ、知識のギャップが業界にさまざまな困難をもたらしています。

“The product segment accounted for the largest share by offering segment in the spatial genomics & transcriptomics market in 2023”.

Products and services divide the spatial genomics & transcriptomics market. In 2023 the product segment held the biggest share. The growing demand for high-resolution spatial gene and protein expression data in research helps to explain the expansion of this area. The main forces behind the market expansion are the expanding uses of consumables and spatial genomics and transcriptomics in drug research and development as well as biomarketer identification. Key element driving development in this market segment is increased investments by market participants in creating various software especially for spatial analysis and introduction of new goods.

“The spatial transcriptomics technique held the highest market share of the spatial genomics and transcriptomics market by technique in 2023”.

Techniques divide the spatial genomics and transcriptomics market into spatial transcriptomics and spatial genomics segments. Driven by growing acceptance of in situ sequencing technologies and more general applications in disease research, the segment of spatial transcriptomics held the biggest share of spatial genomics & transcriptomics market in 2023. Using spatial transcriptomics, one may map gene expression inside the spatial context of a tissue. Combining histology and molecular data reveals how genes are expressed in certain tissue country or region, so providing understanding of cellular organization, function, and disease progression.

“The Asia Pacific region is growing at the highest CAGR in the spatial genomics & transcriptomics market from 2024 to 2029.”The Asia Pacific is estimated to be the fastest-growing segment of the market owing to the aincreasing government efforts to rising healthcare needs, growing government investment in biotechnology, growing demand of precision medicine, rising healthcare expenditure, growing R&D expansion in key markets such as India, China, and Japan, and the favorable regulatory environment in the region. However, North America held the largest share of spatial genomics & transcriptomics market in 2023.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 60% and Demand Side 40%
• By Designation: Managers – 45% CXOs and Director-level – 30%, and Executives – 25%,
• By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5%, and Middle East -5%.

List of Companies Profiled in the Report:

• NanoString Technologies, Inc. (Bruker Spatial Biology, Inc.) (US)
• 10x Genomics (US)
• Bio-Rad Laboratories, Inc. (US)
• Illumina, Inc. (US)
• Bio-Techne (US)
• Seven Bridges Genomics (US)
• Rarecyte, Inc. (US)
• Standard BioTools (US)
• Revvity (US)
• Akoya Biosciences, Inc. (US)
• Natera, Inc. (US)
• VisioPharm A/S (Switzerland)
• Danaher Corporation (US)
• Veracyte, Inc. (US)
• Biomarker Technologies (BMKGENE) (China)
• Macrogen, Inc. (South Korea)
• Miltenyi Biotec (Germany)
• Sony Biotechnology Inc. (US)
• Vizgen Inc. (US)
• BioSpyder, Inc. (US)
• Ionpath, Inc. (US)
• S2 Genomics, Inc. (US)
• Ultivue, Inc. (US)
• Admera Health (US)
• Lunaphore Technologies SA (US)
• Visikol, Inc. (US)
• Rebus Biosystems, Inc. (US)
• Singular Genomics Systems, Inc. (US)
• Cantata Bio (US)
• Nucleai, Inc. (Israel)

Research Coverage:

This research report categorizes the spatial genomics & transcriptomics market by offering (products and services), by technique (spatial transcriptomics and spatial genomics), by type (service) (sample preparation services, sequencing & analytical services, and data visualization & analysis services), by application (translational research and drug discovery & development), by end user (product) (pharmaceutical & biotechnology companies, academic & research institutes, CROs & CDMOs, and clinical diagnostic laboratories), by end user (service) (pharmaceutical & biotechnology companies, academic & research institutes, and other end users), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the spatial genomics & transcriptomics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, product & service portfolio, key strategies such as product & service launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the spatial genomics & transcriptomics market. Competitive analysis of top players and upcoming startups in the spatial genomics & transcriptomics market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall spatial genomics & transcriptomics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (Increasing adoption of spatial genomics and transcriptomics in drug discovery and development, Introduction of novel products, Increasing pharmaceutical R&D investments and public-private funding), restraints (High initial capital investments and maintenance costs, Technical complexity and expertise gap), opportunities (Increasing use of spatial omics for biomarker identification, Increasing demand for precision medicines and targeted drug development), and challenges (Dearth of skilled professionals) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched product/services of the spatial genomics & transcriptomics market
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the spatial genomics & transcriptomics market
• Competitive Assessment: NanoString Technologies, Inc. (Bruker Spatial Biology, Inc.) (US), 10x Genomics (US), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), Bio-Techne (US), Seven Bridges Genomics (US), Rarecyte, Inc. (US), Standard BioTools (US), Revvity (US), Akoya Biosciences, Inc. (US), Natera, Inc. (US), VisioPharm A/S (Switzerland), Danaher Corporation (US), Veracyte, Inc. (US), Biomarker Technologies (BMKGENE) (China), Macrogen, Inc. (South Korea), Miltenyi Biotec (Germany), Sony Biotechnology Inc. (US), Vizgen Inc. (US), BioSpyder, Inc. (US), Ionpath, Inc. (US), S2 Genomics, Inc. (US), Ultivue, Inc. (US), Admera Health (US), Lunaphore Technologies SA (US), Visikol, Inc. (US), Rebus Biosystems, Inc. (US), Singular Genomics Systems, Inc. (US), Cantata Bio (US), and Nucleai, Inc. (Israel).

Table of Contents

1               INTRODUCTION              41

1.1           STUDY OBJECTIVES       41

1.2           MARKET DEFINITION   41

1.3           INCLUSIONS & EXCLUSIONS       42

1.4           STUDY SCOPE   42

1.4.1        SEGMENTS AND REGIONS CONSIDERED              43

1.4.2        YEARS CONSIDERED      44

1.4.3        CURRENCY CONSIDERED            44

1.5           STAKEHOLDERS               44

1.6           SUMMARY OF CHANGES               45

1.6.1        IMPACT OF AI/GEN AI   45

2               RESEARCH METHODOLOGY       46

2.1           RESEARCH DATA              46

2.1.1        SECONDARY DATA          47

2.1.1.1    Objectives of secondary research       47

2.1.2        PRIMARY DATA 47

2.1.2.1    Breakdown of primaries      48

2.1.2.2    Objectives of primary research           48

2.2           MARKET SIZE ESTIMATION         49

2.2.1        REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH)                 50

2.2.1.1    Insights from primary sources            53

2.2.2        SEGMENTAL MARKET ESTIMATION: TOP-DOWN APPROACH (PRODUCT)                53

2.3           GROWTH RATE PROJECTIONS  54

2.4           DATA TRIANGULATION                57

2.5           STUDY ASSUMPTIONS  58

2.6           RESEARCH LIMITATIONS             59

2.7           RISK ANALYSIS  59

3               EXECUTIVE SUMMARY  60

4               PREMIUM INSIGHTS       65

4.1           SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET OVERVIEW          65

4.2           ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET SHARE, BY TECHNIQUE AND COUNTRY (2023)          66

4.3           SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES       67

4.4           SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET SHARE,

BY END USER (2023)        68

4.5           SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET SHARE,

BY END USER (2023)        68

5               MARKET OVERVIEW       69

5.1           INTRODUCTION              69

5.2           MARKET DYNAMICS       69

5.2.1        DRIVERS               70

5.2.1.1    Increasing adoption of spatial genomics and transcriptomics in drug discovery and development        70

5.2.1.2    Introduction of novel products           71

5.2.1.3    Increasing pharmaceutical R&D investments and public-private funding  71

5.2.2        RESTRAINTS      72

5.2.2.1    High initial capital investments and maintenance costs 72

5.2.2.2    Technical complexity and expertise gap           72

5.2.3        OPPORTUNITIES              73

5.2.3.1    Increasing use of spatial omics for biomarker identification                 73

5.2.3.2    Growing demand for precision medicines and targeted drug development          73

5.2.4        CHALLENGES    74

5.2.4.1    Dearth of skilled professionals            74

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS            74

5.4           PRICING ANALYSIS          75

5.4.1        AVERAGE SELLING PRICE TREND OF INSTRUMENTS,

BY KEY PLAYER, 2021–2023            76

5.4.2        AVERAGE SELLING PRICE TREND OF CONSUMABLES,

BY KEY PLAYER, 2021–2023            77

5.4.3        AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2021–2023           78

5.5           SUPPLY CHAIN ANALYSIS             80

5.6           VALUE CHAIN ANALYSIS               82

5.7           ECOSYSTEM ANALYSIS  83

5.8           TECHNOLOGY ANALYSIS             85

5.8.1        KEY TECHNOLOGIES     85

5.8.1.1    In-situ sequencing                85

5.8.1.2    In-situ hybridization             86

5.8.1.3    Single-cell RNA sequencing                86

5.8.2        COMPLEMENTARY TECHNOLOGIES       86

5.8.2.1    Multi-isotope imaging mass spectrometry        86

5.8.2.2    Spatial heatmap    86

5.8.2.3    Differential gene expression analysis                 86

5.8.3        ADJACENT TECHNOLOGIES       87

5.8.3.1    Multi-omics           87

5.8.3.2    Metabolomics        87

5.8.3.3    Single-cell analysis                87

5.9           PATENT ANALYSIS          88

5.10         KEY CONFERENCES & EVENTS, 2025–2026              90

5.11         REGULATORY LANDSCAPE         91

5.11.1      REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  91

5.11.2      REGULATORY FRAMEWORK       93

5.12         PORTER’S FIVE FORCES ANALYSIS           94

5.12.1      THREAT OF NEW ENTRANTS      96

5.12.2      THREAT OF SUBSTITUTES          96

5.12.3      BARGAINING POWER OF BUYERS             96

5.12.4      BARGAINING POWER OF SUPPLIERS       96

5.12.5      INTENSITY OF COMPETITIVE RIVALRY 97

5.13         KEY STAKEHOLDERS & BUYING CRITERIA            97

5.13.1      KEY STAKEHOLDERS IN BUYING PROCESS           97

5.13.2      KEY BUYING CRITERIA, BY END USER (PRODUCT)                 98

5.14         TRADE ANALYSIS             99

5.14.1      IMPORT DATA FOR HS CODE 902790       100

5.14.2      EXPORT DATA FOR HS CODE 902790       100

5.15         INVESTMENT & FUNDING SCENARIO     101

5.16         IMPACT OF AI/GEN AI ON SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET     102

6               SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING           103

6.1           INTRODUCTION              104

6.2           PRODUCTS         104

6.2.1        INSTRUMENTS & SOFTWARE     107

6.2.1.1    Instruments & software to facilitate disease research by enabling detailed spatial mapping and multi-omic analyses          107

6.2.2        CONSUMABLES 110

6.2.2.1    Better reproducible and high-quality data collection to advance spatial genomics research in oncology and precision medicine     110

6.3           SERVICES             113

6.3.1        INCREASING DEMAND FOR HIGH-QUALITY SPATIAL DATA IN PRECISION MEDICINE TO AUGMENT MARKET GROWTH             113

7               SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TECHNIQUE 117

7.1           INTRODUCTION              118

7.2           SPATIAL TRANSCRIPTOMICS     118

7.2.1        IMMUNOHISTOCHEMISTRY       121

7.2.1.1    Increasing applications in biomarker discovery and cellular interactions within tissue architecture to drive segment                121

7.2.2        IMMUNOFLUORESCENCE            124

7.2.2.1    Advanced profiling immune-tumor microenvironments for cancer diagnosis and prognosis to propel segment growth            124

7.2.3        MICROSCOPY-BASED RNA IMAGING       127

7.2.3.1    Better insights into molecular communication within tissue architecture to augment segment growth         127

7.2.4        IN-SITU HYBRIDIZATION             130

7.2.4.1    High-throughput and 3D spatial gene expression analysis in cancer research and developmental biology to drive segment       130

7.2.5        LASER CAPTURE MICRODISSECTION     132

7.2.5.1    Analysis of gene expression data from defined cellular populations to facilitate spatial mapping within tissue sections    132

7.2.6        RNA SEQUENCING          135

7.2.6.1    In-situ RNA sequencing      138

7.2.6.1.1 Integration of ISS with bioinformatics toolkits for data analysis to facilitate interpretation of complex datasets    138

7.2.6.2    Single-cell RNA (SC-RNA) sequencing           140

7.2.6.2.1 Increasing commercial availability of scRNA-seq platforms and advancements in bioinformatics tools to drive segment 140

7.2.6.3    Other RNA sequencing       143

7.2.7        OTHER SPATIAL TRANSCRIPTOMIC TECHNIQUES                 145

7.3           SPATIAL GENOMICS       148

7.3.1        IN-SITU HYBRIDIZATION             151

7.3.1.1    Demand for high-specificity detection platforms to fuel market growth    151

7.3.2        LASER CAPTURE MICRODISSECTION     154

7.3.2.1    Detailed insights into cellular mechanisms and molecular profiles within heterogeneous tissue samples to drive segment  154

7.3.3        GENOMIC SEQUENCING               156

7.3.3.1    Microdissection-based sequencing    159

7.3.3.1.1 Increased demand for precision medicines to boost segment growth    159

7.3.3.2    Chromatin accessibility sequencing  162

7.3.3.2.1 Need for insights into gene regulation and epigenetic modifications to aid segment growth 162

7.3.3.3    Other genomic sequencing 164

7.3.4        OTHER SPATIAL GENOMIC TECHNIQUES             167

8               SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE           170

8.1           INTRODUCTION              171

8.2           SAMPLE PREPARATION SERVICES            171

8.2.1        NEED FOR ACCURATE SPATIAL ANALYSIS OF GENE EXPRESSION WITHIN TISSUE SAMPLES TO SPUR MARKET GROWTH             171

8.3           SEQUENCING & ANALYTICAL SERVICES                174

8.3.1        SEQUENCING & ANALYTICAL SERVICES TO UTILIZE ADVANCED TECHNOLOGIES FOR SEQUENCING AND BIOINFORMATICS ANALYSIS      174

8.4           DATA VISUALIZATION & ANALYSIS SERVICES    177

8.4.1        INCREASED DEMAND FOR ADVANCED TOOLS FOR COMPLEX SPATIAL GENOMICS DATA INTERPRETATION TO SUPPORT MARKET GROWTH     177

9               SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION   180

9.1           INTRODUCTION              181

9.2           TRANSLATIONAL RESEARCH      181

9.2.1        CANCER                184

9.2.1.1    Spatial genomics and transcriptomics to map precise locations of DNA and RNA within tumor tissues in cancer research                 184

9.2.2        IMMUNOLOGY 187

9.2.2.1    Need for better understanding of immune cell interactions and tissue-specific immune responses to propel segment growth        187

9.2.3        NEUROSCIENCE               189

9.2.3.1    Increased focus on mapping cellular diversity for analyzing brain function and dysfunction to aid market growth               189

9.2.4        INFECTIOUS DISEASES 192

9.2.4.1    Need for enhanced understanding of pathogen-host interactions at tissue level to drive adoption          192

9.2.5        OTHER DISEASES             195

9.3           DRUG DISCOVERY & DEVELOPMENT     197

9.3.1        RISING USE OF RNA-SEQ IN DISEASE MANAGEMENT DRUG DISCOVERY TO DRIVE MARKET  197

10            SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY END USER     201

10.1         INTRODUCTION              202

10.2         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES                 202

10.2.1      PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO TRANSFORM DISEASE RESEARCH AND STREAMLINE DRUG TARGET VALIDATION   202

10.3         ACADEMIC & RESEARCH INSTITUTES    205

10.3.1      FOCUS ON FOUNDATIONAL DISCOVERIES AND CELLULAR INSIGHTS ABOUT COMPLEX BIOLOGICAL SYSTEMS TO AID MARKET GROWTH          205

10.4         CROS & CDMOS                 208

10.4.1      GROWING DEMAND FOR PRECISE SPATIAL MOLECULAR INSIGHTS TO PROPEL MARKET GROWTH 208

10.5         CLINICAL DIAGNOSTIC LABORATRIES  211

10.5.1      IMPROVED DIAGNOSTIC ACCURACY IN PATHOGEN DETECTION AND GENOMIC ANALYSIS TO AID MARKET GROWTH             211

11            SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER 215

11.1         INTRODUCTION              216

11.2         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES                 216

11.2.1      PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO OPTIMIZE BIOMARKER DEVELOPMENT AND IMPROVE CLINICAL TRIAL DESIGN              216

11.3         ACADEMIC & RESEARCH INSTITUTES    219

11.3.1      NEED FOR TOOLS FOR MAPPING CELLULAR ENVIRONMENTS AND STUDYING DISEASE MECHANISMS TO PROPEL MARKET GROWTH         219

11.4         OTHER END USERS         222

12            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY REGION                225

12.1         INTRODUCTION              226

12.2         NORTH AMERICA             227

12.2.1      NORTH AMERICA: MACROECONOMIC OUTLOOK                 232

12.2.2      US           233

12.2.2.1  US to dominate North American spatial genomics & transcriptomics market during forecast period                233

12.2.3      CANADA               238

12.2.3.1  Favorable government initiatives and high incidence of infectious diseases to support market growth    238

12.3         EUROPE               242

12.3.1      EUROPE: MACROECONOMIC OUTLOOK               248

12.3.2      GERMANY           249

12.3.2.1  Advanced genomics research and presence of several key companies to spur market growth      249

12.3.3      UK          253

12.3.3.1  Increasing government funding and rising demand for new diagnostic biomarkers to aid market growth    253

12.3.4      FRANCE                258

12.3.4.1  Increasing investments in life science R&D and rising number of biotech companies to propel market growth    258

12.3.5      ITALY    262

12.3.5.1  Increasing focus on neuroscience and rare disease research to augment market growth      262

12.3.6      SPAIN    267

12.3.6.1  Focus on advanced cancer research and increased need for personalized medicines to propel market growth            267

12.3.7      REST OF EUROPE             271

12.4         ASIA PACIFIC     276

12.4.1      ASIA PACIFIC: MACROECONOMIC OUTLOOK     283

12.4.2      CHINA  284

12.4.2.1  Increasing R&D spending by government and biopharma companies to propel market growth  284

12.4.3      JAPAN   289

12.4.3.1  Favorable government policies and high R&D funding to boost market growth       289

12.4.4      INDIA    293

12.4.4.1  Increasing collaborations between hospitals and diagnostics centers to boost market growth          293

12.4.5      SOUTH KOREA  298

12.4.5.1  Increased research on advanced precision medicines and well-established biotechnology infrastructure to aid market growth    298

12.4.6      AUSTRALIA         302

12.4.6.1  Strategic focus on advancing cancer research and precision oncology to boost market growth       302

12.4.7      REST OF ASIA PACIFIC   307

12.5         LATIN AMERICA                312

12.5.1      LATIN AMERICA: MACROECONOMIC OUTLOOK                 317

12.5.2      BRAZIL 318

12.5.2.1  Increasing adoption of biomarkers for drug discovery & development to drive market              318

12.5.3      MEXICO                322

12.5.3.1  Favorable funding scenario in biotechnology sector and high funding in biomanufacturing to augment market growth               322

12.5.4      REST OF LATIN AMERICA             326

12.6         MIDDLE EAST   331

12.6.1      LOWER R&D INVESTMENTS AND WEAK INFRASTRUCTURAL DEVELOPMENTS TO HINDER MARKET GROWTH             331

12.6.2      MIDDLE EAST: MACROECONOMIC OUTLOOK   335

12.7         AFRICA 336

12.7.1      INCREASING FUNDING AND PARTNERSHIPS IN RESEARCH SECTOR TO SUPPORT GROWTH OF BIOTECHNOLOGY INDUSTRY    336

12.7.2      AFRICA: MACROECONOMIC OUTLOOK 341

13            COMPETITIVE LANDSCAPE         343

13.1         INTRODUCTION              343

13.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            343

13.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET 344

13.3         REVENUE ANALYSIS, 2019−2023                 348

13.4         MARKET SHARE ANALYSIS, 2023                 349

13.4.1      SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET               349

13.4.2      SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET               351

13.4.3      RANKING OF KEY MARKET PLAYERS       351

13.5         COMPANY VALUATION & FINANCIAL METRICS 352

13.5.1      COMPANY VALUATION 352

13.5.2      FINANCIAL METRICS      352

13.6         BRAND/PRODUCT COMPARISON             353

13.7         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023                 355

13.7.1      STARS   355

13.7.2      EMERGING LEADERS     355

13.7.3      PERVASIVE PLAYERS      355

13.7.4      PARTICIPANTS 355

13.7.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         357

13.7.5.1  Company footprint               357

13.7.5.2  Region footprint   358

13.7.5.3  Offering footprint 359

13.7.5.4  Technique footprint             360

13.7.5.5  Application footprint            361

13.8         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        362

13.8.1      PROGRESSIVE COMPANIES         362

13.8.2      RESPONSIVE COMPANIES            362

13.8.3      DYNAMIC COMPANIES  362

13.8.4      STARTING BLOCKS         362

13.8.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 364

13.8.5.1  Detailed list of key startups/SMEs    364

13.8.5.2  Competitive benchmarking of key startups/SMEs          365

13.9         COMPETITIVE SCENARIO             366

13.9.1      PRODUCT LAUNCHES   366

13.9.2      DEALS  367

13.9.3      EXPANSIONS     368

14            COMPANY PROFILES      369

14.1         KEY PLAYERS     369

14.1.1      10X GENOMICS 369

14.1.1.1  Business overview 369

14.1.1.2  Products/Services/Solutions offered 371

14.1.1.3  Recent developments           372

14.1.1.3.1                Product launches  372

14.1.1.3.2                Deals      373

14.1.1.3.3                Expansions             373

14.1.1.4  MnM view              374

14.1.1.4.1                Key strengths        374

14.1.1.4.2                Strategic choices   374

14.1.1.4.3                Weaknesses and competitive threats 374

14.1.2      BIO-TECHNE     375

14.1.2.1  Business overview 375

14.1.2.2  Products/Services/Solutions offered 376

14.1.2.3  Recent developments           378

14.1.2.3.1                Product launches  378

14.1.2.3.2                Deals      379

14.1.2.3.3                Expansions             379

14.1.2.4  MnM view              380

14.1.2.4.1                Key strengths        380

14.1.2.4.2                Strategic choices   380

14.1.2.4.3                Weaknesses and competitive threats 380

14.1.3      NANOSTRING TECHNOLOGIES, INC. (BRUKER SPATIAL BIOLOGY, INC.) 381

14.1.3.1  Business overview 381

14.1.3.2  Products/Services/Solutions offered 383

14.1.3.3  Recent developments           384

14.1.3.3.1                Product launches  384

14.1.3.3.2                Deals      385

14.1.3.4  MnM view              386

14.1.3.4.1                Key strengths        386

14.1.3.4.2                Strategic choices   386

14.1.3.4.3                Weaknesses and competitive threats 386

14.1.4      STANDARD BIOTOOLS 387

14.1.4.1  Business overview 387

14.1.4.2  Products/Services/Solutions offered 389

14.1.4.3  Recent developments           391

14.1.4.3.1                Product launches  391

14.1.4.3.2                Deals      391

14.1.4.4  MnM view              392

14.1.4.4.1                Key strengths        392

14.1.4.4.2                Strategic choices   392

14.1.4.4.3                Weaknesses and competitive threats 392

14.1.5      ILLUMINA, INC. 393

14.1.5.1  Business overview 393

14.1.5.2  Products/Services/Solutions offered 395

14.1.5.3  Recent developments           396

14.1.5.3.1                Product launches  396

14.1.5.3.2                Deals      396

14.1.5.4  MnM view              397

14.1.5.4.1                Key strengths        397

14.1.5.4.2                Strategic choices   397

14.1.5.4.3                Weaknesses and competitive threats 397

14.1.6      BIO-RAD LABORATORIES, INC.  398

14.1.6.1  Business overview 398

14.1.6.2  Products/Services/Solutions offered 399

14.1.6.3  Recent developments           400

14.1.6.3.1                Product launches  400

14.1.6.3.2                Deals      400

14.1.7      AKOYA BIOSCIENCES, INC.          401

14.1.7.1  Business overview 401

14.1.7.2  Products/Services/Solutions offered 402

14.1.7.3  Recent developments           402

14.1.7.3.1                Product launches  402

14.1.7.3.2                Deals      403

14.1.7.3.3                Expansions             404

14.1.8      VISIOPHARM A/S              405

14.1.8.1  Business overview 405

14.1.8.2  Products/Services/Solutions offered 405

14.1.8.3  Recent developments           406

14.1.8.3.1                Product launches  406

14.1.8.3.2                Deals      406

14.1.9      DANAHER CORPORATION           407

14.1.9.1  Business overview 407

14.1.9.2  Products/Services/Solutions offered 409

14.1.9.3  Recent developments           409

14.1.9.3.1                Deals      409

14.1.10   SEVEN BRIDGES GENOMICS       410

14.1.10.1                 Business overview 410

14.1.10.2                 Products/Services/Solutions offered 410

14.1.10.3                 Recent developments           411

14.1.10.3.1             Deals      411

14.1.11   REVVITY               412

14.1.11.1                 Business overview 412

14.1.11.2                 Products/Services/Solutions offered 414

14.1.11.3                 Recent developments           414

14.1.11.3.1             Product launches & approvals            414

14.1.11.3.2             Deals      415

14.1.12   VIZGEN INC.       416

14.1.12.1                 Business overview 416

14.1.12.2                 Products/Services/Solutions offered 416

14.1.12.3                 Recent developments           417

14.1.12.3.1             Product launches  417

14.1.12.3.2             Deals      418

14.1.13   VERACYTE, INC.                419

14.1.13.1                 Business overview 419

14.1.13.2                 Products/Services/Solutions offered 419

14.1.14   NATERA, INC.    420

14.1.14.1                 Business overview 420

14.1.14.2                 Products/Services/Solutions offered 422

14.1.14.3                 Recent developments           422

14.1.14.3.1             Product launches  422

14.1.14.3.2             Expansions             423

14.1.15   MACROGEN INC.              424

14.1.15.1                 Business overview 424

14.1.15.2                 Products/Services/Solutions offered 425

14.1.15.3                 Recent developments           425

14.1.15.3.1             Deals      425

14.1.16   MILTENYI BIOTEC           426

14.1.16.1                 Business overview 426

14.1.16.2                 Products/Services/Solutions offered 426

14.1.16.3                 Recent developments           427

14.1.16.3.1             Deals      427

14.2         OTHER PLAYERS              428

14.2.1      BIOMARKER TECHNOLOGIES (BMKGENE)           428

14.2.2      ULTIVUE, INC.  429

14.2.3      RARECYTE, INC.                430

14.2.4      S2 GENOMICS, INC.         431

14.2.5      ADMERA HEALTH            432

14.2.6      SONY BIOTECHNOLOGY INC.    433

14.2.7      CANTATA BIO   434

14.2.8      NUCLEAI, INC.   435

14.2.9      VISIKOL, INC.     436

14.2.10   IONPATH, INC. 437

14.2.11   BIOSPYDER, INC.              438

14.2.12   SINGULAR GENOMICS SYSTEMS, INC.    439

14.2.13   LUNAPHORE TECHNOLOGIES SA             440

14.2.14   REBUS BIOSYSTEMS, INC.             441

15            APPENDIX           442

15.1         DISCUSSION GUIDE        442

15.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                446

15.3         CUSTOMIZATION OPTIONS        448

15.4         RELATED REPORTS         448

15.5         AUTHOR DETAILS           449

LIST OF TABLES

TABLE 1                SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: INCLUSIONS & EXCLUSIONS   42

TABLE 2                IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS  56

TABLE 3                SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: RISK ANALYSIS              59

TABLE 4                SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: IMPACT ANALYSIS       70

TABLE 5                AVERAGE SELLING PRICE TREND OF INSTRUMENTS,

BY KEY PLAYER, 2021–2023 (USD)              76

TABLE 6                AVERAGE SELLING PRICE TREND OF CONSUMABLES,

BY KEY PLAYER, 2021–2023 (USD)              77

TABLE 7                AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2023 (USD) 78

TABLE 8                AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2022 (USD) 79

TABLE 9                AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2021 (USD) 79

TABLE 10              SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: ROLE IN ECOSYSTEM 85

TABLE 11              SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2021–2023        89

TABLE 12              SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026                90

TABLE 13              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  91

TABLE 14              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  91

TABLE 15              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  92

TABLE 16              REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  92

TABLE 17              SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: REGULATORY SCENARIO,

BY COUNTRY     93

TABLE 18              SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: PORTER’S FIVE FORCES             94

TABLE 19              INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)      97

TABLE 20              KEY BUYING CRITERIA, BY END USER (PRODUCT)        98

TABLE 21              IMPORT DATA FOR HS CODE 902790, BY COUNTRY, 2021–2022 (USD MILLION)     100

TABLE 22              EXPORT DATA FOR HS CODE 902790, BY COUNTRY, 2021–2022 (USD MILLION)     100

TABLE 23              IMMUNOFLUORESCENCE QUANTITATIVE ANALYZERS IMPORT/EXPORT DATA, MARCH 2023–FEBRUARY 2024        100

TABLE 24              SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               104

TABLE 25              SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         104

TABLE 26              SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET

FOR INSTRUMENTS & SOFTWARE, BY VOLUME, 2022–2029 (UNITS)                105

TABLE 27              SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY REGION, 2022–2029 (USD MILLION)   105

TABLE 28              NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)       106

TABLE 29              EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               106

TABLE 30              ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               107

TABLE 31              LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)       107

TABLE 32              SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY REGION, 2022–2029 (USD MILLION)          108

TABLE 33              NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)     108

TABLE 34              EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)     109

TABLE 35              ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)     109

TABLE 36              LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)     110

TABLE 37              SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)       111

TABLE 38              NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)               111

TABLE 39              EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)               112

TABLE 40              ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET

FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)                 112

TABLE 41              LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)               113

TABLE 42              SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY REGION, 2022–2029 (USD MILLION)   114

TABLE 43              NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)       114

TABLE 44              EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               115

TABLE 45              ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               115

TABLE 46              LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               116

TABLE 47              SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          118

TABLE 48              SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         119

TABLE 49              SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY REGION, 2022–2029 (USD MILLION)   119

TABLE 50              NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               120

TABLE 51              EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               120

TABLE 52              ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               121

TABLE 53              LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               121

TABLE 54              SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY REGION, 2022–2029 (USD MILLION)       122

TABLE 55              NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2022–2029 (USD MILLION)     122

TABLE 56              EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2022–2029 (USD MILLION)     123

TABLE 57              ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2022–2029 (USD MILLION)     123

TABLE 58              LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2022–2029 (USD MILLION)     124

TABLE 59              SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY REGION, 2022–2029 (USD MILLION) 125

TABLE 60              NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2022–2029 (USD MILLION)     125

TABLE 61              EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2022–2029 (USD MILLION)     126

TABLE 62              ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2022–2029 (USD MILLION)     126

TABLE 63              LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2022–2029 (USD MILLION)     127

TABLE 64              SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY REGION, 2022–2029 (USD MILLION)            127

TABLE 65              NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2022–2029 (USD MILLION)               128

TABLE 66              EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2022–2029 (USD MILLION)               128

TABLE 67              ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2022–2029 (USD MILLION)               129

TABLE 68              LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2022–2029 (USD MILLION)               129

TABLE 69              SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION,

BY REGION, 2022–2029 (USD MILLION)   130

TABLE 70              NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022–2029 (USD MILLION)     130

TABLE 71              EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022–2029 (USD MILLION)     131

TABLE 72              ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022–2029 (USD MILLION)     131

TABLE 73              LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022–2029 (USD MILLION)     132

TABLE 74              SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY REGION, 2022–2029 (USD MILLION)            133

TABLE 75              NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022–2029 (USD MILLION)               133

TABLE 76              EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022–2029 (USD MILLION)               134

TABLE 77              ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022–2029 (USD MILLION)               134

TABLE 78              LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022–2029 (USD MILLION)               135

TABLE 79              SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING,

BY REGION, 2022–2029 (USD MILLION)   135

TABLE 80              NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET

FOR RNA SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)            136

TABLE 81              EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)            136

TABLE 82              ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)            137

TABLE 83              LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)            137

TABLE 84             IN-SITU RNA SEQUENCING PRODUCTS MARKET, BY REGION,

2022–2029 (USD MILLION)            138

TABLE 85              NORTH AMERICA: IN-SITU RNA SEQUENCING PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               138

TABLE 86              EUROPE: IN-SITU RNA SEQUENCING PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               139

TABLE 87              ASIA PACIFIC: IN-SITU RNA SEQUENCING PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               139

TABLE 88              LATIN AMERICA: IN-SITU RNA SEQUENCING PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               140

TABLE 89              SINGLE-CELL RNA (SC-RNA) SEQUENCING PRODUCTS MARKET,

BY REGION, 2022–2029 (USD MILLION)   141

TABLE 90              NORTH AMERICA: SINGLE-CELL RNA (SC-RNA) SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141

TABLE 91              EUROPE: SINGLE-CELL RNA (SC-RNA) SEQUENCING PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               142

TABLE 92              ASIA PACIFIC: SINGLE-CELL RNA (SC-RNA) SEQUENCING PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               142

TABLE 93              LATIN AMERICA: SINGLE-CELL RNA (SC-RNA) SEQUENCING PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               143

TABLE 94              OTHER RNA SEQUENCING PRODUCTS MARKET, BY REGION,

2022–2029 (USD MILLION)            143

TABLE 95              NORTH AMERICA: OTHER RNA SEQUENCING PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               144

TABLE 96              EUROPE: OTHER RNA SEQUENCING PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               144

TABLE 97              ASIA PACIFIC: OTHER RNA SEQUENCING PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               145

TABLE 98              LATIN AMERICA: OTHER RNA SEQUENCING PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               145

TABLE 99              SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER TRANSCRIPTOMICS TECHNIQUES, BY REGION, 2022–2029 (USD MILLION)          146

TABLE 100            NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 146

TABLE 101            EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 147

TABLE 102            ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 147

TABLE 103            LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 148

TABLE 104            SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)                148

TABLE 105            SPATIAL GENOMICS PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)          149

TABLE 106            NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               149

TABLE 107            EUROPE: SPATIAL GENOMICS PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               149

TABLE 108            ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               150

TABLE 109            LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               150

TABLE 110            SPATIAL GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION,

BY REGION, 2022–2029 (USD MILLION)   151

TABLE 111            NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022–2029 (USD MILLION)     152

TABLE 112            EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION,

BY COUNTRY, 2022–2029 (USD MILLION)               152

TABLE 113            ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022–2029 (USD MILLION) 153

TABLE 114            LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022–2029 (USD MILLION)     153

TABLE 115            SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY REGION, 2022–2029 (USD MILLION) 154

TABLE 116            NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022–2029 (USD MILLION)               154

TABLE 117            EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022–2029 (USD MILLION)     155

TABLE 118            ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022–2029 (USD MILLION)     155

TABLE 119            LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022–2029 (USD MILLION)               156

TABLE 120            SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,

BY TYPE, 2022–2029 (USD MILLION)         156

TABLE 121            SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,

BY REGION, 2022–2029 (USD MILLION)   157

TABLE 122            NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)     157

TABLE 123            EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION) 158

TABLE 124            ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION) 158

TABLE 125            LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)     159

TABLE 126            MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET,

BY REGION, 2022–2029 (USD MILLION)   160

TABLE 127            NORTH AMERICA: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 160

TABLE 128            EUROPE: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               161

TABLE 129            ASIA PACIFIC: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               161

TABLE 130            LATIN AMERICA: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               162

TABLE 131            CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET,

BY REGION, 2022–2029 (USD MILLION)   162

TABLE 132            NORTH AMERICA: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 163

TABLE 133            EUROPE: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               163

TABLE 134            ASIA PACIFIC: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               164

TABLE 135            LATIN AMERICA: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 164

TABLE 136            OTHER GENOMIC SEQUENCING PRODUCTS MARKET,

BY REGION, 2022–2029 (USD MILLION)   165

TABLE 137            NORTH AMERICA: OTHER GENOMIC SEQUENCING PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               165

TABLE 138            EUROPE: OTHER GENOMIC SEQUENCING PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               166

TABLE 139            ASIA PACIFIC: OTHER GENOMIC SEQUENCING PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               166

TABLE 140            LATIN AMERICA: OTHER GENOMIC SEQUENCING PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               167

TABLE 141            SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMIC TECHNIQUES, BY REGION, 2022–2029 (USD MILLION) 167

TABLE 142            NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMIC TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 168

TABLE 143            EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMIC TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION)     168

TABLE 144            ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMIC TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION)     169

TABLE 145            LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMIC TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 169

TABLE 146            SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         171

TABLE 147            SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)       172

TABLE 148            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)               172

TABLE 149            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)               173

TABLE 150            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)               173

TABLE 151            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)               174

TABLE 152            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEQUENCING & ANALYTICAL SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)          174

TABLE 153            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            175

TABLE 154            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 175

TABLE 155            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 176

TABLE 156            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 176

TABLE 157            SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)          177

TABLE 158            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 178

TABLE 159            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 178

TABLE 160            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 179

TABLE 161            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 179

TABLE 162            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       181

TABLE 163            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION) 182

TABLE 164            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY REGION, 2022–2029 (USD MILLION)       182

TABLE 165            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)               183

TABLE 166            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)               183

TABLE 167            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)               184

TABLE 168            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)               184

TABLE 169            TRANSLATIONAL RESEARCH MARKET FOR CANCER,

BY REGION, 2022–2029 (USD MILLION)   185

TABLE 170            NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR CANCER,

BY COUNTRY, 2022–2029 (USD MILLION)               185

TABLE 171            EUROPE: TRANSLATIONAL RESEARCH MARKET FOR CANCER,

BY COUNTRY, 2022–2029 (USD MILLION)               186

TABLE 172            ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR CANCER,

BY COUNTRY, 2022–2029 (USD MILLION)               186

TABLE 173            LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR CANCER,

BY COUNTRY, 2022–2029 (USD MILLION)               187

TABLE 174            TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY,

BY REGION, 2022–2029 (USD MILLION)   187

TABLE 175            NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY,

BY COUNTRY, 2022–2029 (USD MILLION)               188

TABLE 176            EUROPE: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY,

BY COUNTRY, 2022–2029 (USD MILLION)               188

TABLE 177            ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY,

BY COUNTRY, 2022–2029 (USD MILLION)               189

TABLE 178            LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY,

BY COUNTRY, 2022–2029 (USD MILLION)               189

TABLE 179            TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE,

BY REGION, 2022–2029 (USD MILLION)   190

TABLE 180            NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE,

BY COUNTRY, 2022–2029 (USD MILLION)               190

TABLE 181            EUROPE: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE,

BY COUNTRY, 2022–2029 (USD MILLION)               191

TABLE 182            ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE,

BY COUNTRY, 2022–2029 (USD MILLION)               191

TABLE 183            LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE,

BY COUNTRY, 2022–2029 (USD MILLION)               192

TABLE 184            TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES,

BY REGION, 2022–2029 (USD MILLION)   193

TABLE 185            NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 193

TABLE 186            EUROPE: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES,

BY COUNTRY, 2022–2029 (USD MILLION)               194

TABLE 187            ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES,

BY COUNTRY, 2022–2029 (USD MILLION)               194

TABLE 188            LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 195

TABLE 189            TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES,

BY REGION, 2022–2029 (USD MILLION)   195

TABLE 190            NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES,

BY COUNTRY, 2022–2029 (USD MILLION)               196

TABLE 191            EUROPE: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES,

BY COUNTRY, 2022–2029 (USD MILLION)               196

TABLE 192            ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES,

BY COUNTRY, 2022–2029 (USD MILLION)               197

TABLE 193            LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES,

BY COUNTRY, 2022–2029 (USD MILLION)               197

TABLE 194            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)            198

TABLE 195            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)                 198

TABLE 196            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)                 199

TABLE 197            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)                 199

TABLE 198            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)                 200

TABLE 199            SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               202

TABLE 200            SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION,

2022–2029 (USD MILLION)            203

TABLE 201            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,

BY COUNTRY, 2022–2029 (USD MILLION)               203

TABLE 202            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,

BY COUNTRY, 2022–2029 (USD MILLION)               204

TABLE 203            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,

2022–2029 (USD MILLION)            204

TABLE 204            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,

BY COUNTRY, 2022–2029 (USD MILLION)               205

TABLE 205            SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)   206

TABLE 206            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY,

2022–2029 (USD MILLION)            206

TABLE 207            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)            207

TABLE 208            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)            207

TABLE 209            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY,

2022–2029 (USD MILLION)            208

TABLE 210            SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2022–2029 (USD MILLION)       209

TABLE 211            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)               209

TABLE 212            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET

FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)                 210

TABLE 213            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET

FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)                 210

TABLE 214            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)               211

TABLE 215            SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION) 212

TABLE 216            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY,

2022–2029 (USD MILLION)            212

TABLE 217            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)            213

TABLE 218            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)            213

TABLE 219            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY,

2022–2029 (USD MILLION)            214

TABLE 220            SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               216

TABLE 221            SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,

BY REGION, 2022–2029 (USD MILLION)   217

TABLE 222            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,

BY COUNTRY, 2022–2029 (USD MILLION)               217

TABLE 223            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,

BY COUNTRY, 2022–2029 (USD MILLION)               218

TABLE 224            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET

FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,

BY COUNTRY, 2022–2029 (USD MILLION)               218

TABLE 225            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,

BY COUNTRY, 2022–2029 (USD MILLION)               219

TABLE 226            SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)   220

TABLE 227            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY,

2022–2029 (USD MILLION)            220

TABLE 228            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)            221

TABLE 229            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)            221

TABLE 230            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY,

2022–2029 (USD MILLION)            222

TABLE 231            SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET

FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)                 222

TABLE 232            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)               223

TABLE 233            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET

FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)            223

TABLE 234            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET

FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)            224

TABLE 235            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)               224

TABLE 236            SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY REGION, 2022–2029 (USD MILLION)   226

TABLE 237            SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY REGION, 2022–2029 (USD MILLION)   226

TABLE 238            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)       228

TABLE 239            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)       228

TABLE 240            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               228

TABLE 241            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 229

TABLE 242            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)            229

TABLE 243            NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         229

TABLE 244            NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET

FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)                 230

TABLE 245            NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         230

TABLE 246            NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR

GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)                 230

TABLE 247            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 231

TABLE 248            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       231

TABLE 249            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET

FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)            231

TABLE 250            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)       232

TABLE 251            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)       232

TABLE 252            NORTH AMERICA: KEY MACROINDICATORS                 233

TABLE 253            US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               234

TABLE 254            US: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         234

TABLE 255            US: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          234

TABLE 256            US: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         235

TABLE 257            US: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING,

BY TYPE, 2022–2029 (USD MILLION)         235

TABLE 258            US: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            236

TABLE 259            US: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,

BY TYPE, 2022–2029 (USD MILLION)         236

TABLE 260            US: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         236

TABLE 261            US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       237

TABLE 262            US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION) 237

TABLE 263            US: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               237

TABLE 264            US: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               238

TABLE 265            CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               238

TABLE 266            CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         239

TABLE 267            CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          239

TABLE 268            CANADA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         239

TABLE 269            CANADA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET

FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)                 240

TABLE 270            CANADA: SPATIAL GENOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         240

TABLE 271            CANADA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)            240

TABLE 272            CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         241

TABLE 273            CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       241

TABLE 274            CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET

FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)            241

TABLE 275            CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               242

TABLE 276            CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               242

TABLE 277            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               243

TABLE 278            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               243

TABLE 279            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               244

TABLE 280            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         244

TABLE 281            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          244

TABLE 282            EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         245

TABLE 283            EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)       245

TABLE 284            EUROPE: SPATIAL GENOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         246

TABLE 285            EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)            246

TABLE 286            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         246

TABLE 287            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       247

TABLE 288            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET

FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)            247

TABLE 289            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               247

TABLE 290            EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               248

TABLE 291            EUROPE: KEY MACROINDICATORS          249

TABLE 292            GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               249

TABLE 293            GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         250

TABLE 294            GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          250

TABLE 295            GERMANY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         250

TABLE 296            GERMANY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET

FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)                 251

TABLE 297            GERMANY: SPATIAL GENOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         251

TABLE 298            GERMANY: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)            251

TABLE 299            GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         252

TABLE 300            GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       252

TABLE 301            GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)         252

TABLE 302            GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               253

TABLE 303            GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               253

TABLE 304            UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               254

TABLE 305            UK: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         254

TABLE 306            UK: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          254

TABLE 307            UK: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         255

TABLE 308            UK: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING,

BY TYPE, 2022–2029 (USD MILLION)         255

TABLE 309            UK: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            256

TABLE 310            UK: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,

BY TYPE, 2022–2029 (USD MILLION)         256

TABLE 311            UK: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         256

TABLE 312            UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       257

TABLE 313            UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION) 257

TABLE 314            UK: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               257

TABLE 315            UK: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               258

TABLE 316            FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               258

TABLE 317            FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         259

TABLE 318            FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          259

TABLE 319            FRANCE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         259

TABLE 320            FRANCE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)       260

TABLE 321            FRANCE: SPATIAL GENOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         260

TABLE 322            FRANCE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,

BY TYPE, 2022–2029 (USD MILLION)         260

TABLE 323            FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         261

TABLE 324            FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       261

TABLE 325            FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR

TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)            261

TABLE 326            FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               262

TABLE 327            FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               262

TABLE 328            ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               263

TABLE 329            ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         263

TABLE 330            ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          263

TABLE 331            ITALY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         264

TABLE 332            ITALY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET

FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)                 264

TABLE 333            ITALY: SPATIAL GENOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         265

TABLE 334            ITALY: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,

BY TYPE, 2022–2029 (USD MILLION)         265

TABLE 335            ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         265

TABLE 336            ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       266

TABLE 337            ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET

FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)            266

TABLE 338            ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               266

TABLE 339            ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               267

TABLE 340            SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               267

TABLE 341            SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         268

TABLE 342            SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          268

TABLE 343            SPAIN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         268

TABLE 344            SPAIN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET

FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)                 269

TABLE 345            SPAIN: SPATIAL GENOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         269

TABLE 346            SPAIN: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,

BY TYPE, 2022–2029 (USD MILLION)         269

TABLE 347            SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         270

TABLE 348            SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       270

TABLE 349            SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET

FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)            270

TABLE 350            SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               271

TABLE 351            SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               271

TABLE 352            REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               272

TABLE 353            REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 272

TABLE 354            REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)            272

TABLE 355            REST OF EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         273

TABLE 356            REST OF EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET

FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)                 273

TABLE 357            REST OF EUROPE: SPATIAL GENOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         274

TABLE 358            REST OF EUROPE: SPATIAL GENOMICS PRODUCTS MARKET

FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)            274

TABLE 359            REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 274

TABLE 360            REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       275

TABLE 361            REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)         275

TABLE 362            REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)       275

TABLE 363            REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)       276

TABLE 364            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               278

TABLE 365            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               278

TABLE 366            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               279

TABLE 367            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         279

TABLE 368            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          279

TABLE 369            ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         280

TABLE 370            ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET

FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)                 280

TABLE 371            ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         281

TABLE 372            ASIA PACIFIC: SPATIAL GENOMICS MARKET PRODUCTS FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION) 281

TABLE 373            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         281

TABLE 374            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       282

TABLE 375            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)         282

TABLE 376            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               282

TABLE 377            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               283

TABLE 378            ASIA PACIFIC: KEY MACROINDICATORS                 284

TABLE 379            CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               285

TABLE 380            CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         285

TABLE 381            CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          285

TABLE 382            CHINA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         286

TABLE 383            CHINA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)       286

TABLE 384            CHINA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            287

TABLE 385            CHINA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,

BY TYPE, 2022–2029 (USD MILLION)         287

TABLE 386            CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         287

TABLE 387            CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       288

TABLE 388            CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)         288

TABLE 389            CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               288

TABLE 390            CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               289

TABLE 391            JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               289

TABLE 392            JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         290

TABLE 393            JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          290

TABLE 394            JAPAN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         290

TABLE 395            JAPAN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR

RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION) 291

TABLE 396            JAPAN: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            291

TABLE 397            JAPAN: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,

BY TYPE, 2022–2029 (USD MILLION)         291

TABLE 398            JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         292

TABLE 399            JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       292

TABLE 400            JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET

FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)            292

TABLE 401            JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               293

TABLE 402            JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               293

TABLE 403            INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               294

TABLE 404            INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         294

TABLE 405            INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          294

TABLE 406            INDIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         295

TABLE 407            INDIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR

RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION) 295

TABLE 408            INDIA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            296

TABLE 409            INDIA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,

BY TYPE, 2022–2029 (USD MILLION)         296

TABLE 410            INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         296

TABLE 411            INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       297

TABLE 412            INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)         297

TABLE 413            INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               297

TABLE 414            INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               298

TABLE 415            SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               298

TABLE 416            SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         299

TABLE 417            SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          299

TABLE 418            SOUTH KOREA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         299

TABLE 419            SOUTH KOREA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET

FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)                 300

TABLE 420            SOUTH KOREA: SPATIAL GENOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         300

TABLE 421            SOUTH KOREA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)            300

TABLE 422            SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         301

TABLE 423            SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       301

TABLE 424            SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET

FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)            301

TABLE 425            SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               302

TABLE 426            SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               302

TABLE 427            AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               303

TABLE 428            AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         303

TABLE 429            AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          303

TABLE 430            AUSTRALIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         304

TABLE 431            AUSTRALIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET

FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)                 304

TABLE 432            AUSTRALIA: SPATIAL GENOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         305

TABLE 433            AUSTRALIA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)            305

TABLE 434            AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         305

TABLE 435            AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       306

TABLE 436            AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)         306

TABLE 437            AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               306

TABLE 438            AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               307

TABLE 439            REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               307

TABLE 440            REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 308

TABLE 441            REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)            308

TABLE 442            REST OF ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         308

TABLE 443            REST OF ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET

FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)                 309

TABLE 444            REST OF ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         309

TABLE 445            REST OF ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET

FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)            309

TABLE 446            REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 310

TABLE 447            REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       310

TABLE 448            REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET

FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)            310

TABLE 449            REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)       311

TABLE 450            REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)       311

TABLE 451            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)       312

TABLE 452            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               312

TABLE 453            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               313

TABLE 454            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 313

TABLE 455            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)            313

TABLE 456            LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         314

TABLE 457            LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET

FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)                 314

TABLE 458            LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         315

TABLE 459            LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)            315

TABLE 460            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         315

TABLE 461            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       316

TABLE 462            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)         316

TABLE 463            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)       316

TABLE 464            LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               317

TABLE 465            LATIN AMERICA: KEY MACROINDICATORS                 317

TABLE 466            BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               318

TABLE 467            BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         318

TABLE 468            BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          319

TABLE 469            BRAZIL: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         319

TABLE 470            BRAZIL: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)       319

TABLE 471            BRAZIL: SPATIAL GENOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         320

TABLE 472            BRAZIL: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,

BY TYPE, 2022–2029 (USD MILLION)         320

TABLE 473            BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         320

TABLE 474            BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       321

TABLE 475            BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET

FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)            321

TABLE 476            BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               321

TABLE 477            BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               322

TABLE 478            MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               322

TABLE 479            MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         323

TABLE 480            MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          323

TABLE 481            MEXICO: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         323

TABLE 482            MEXICO: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)       324

TABLE 483            MEXICO: SPATIAL GENOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         324

TABLE 484            MEXICO: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,

BY TYPE, 2022–2029 (USD MILLION)         324

TABLE 485            MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         325

TABLE 486            MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       325

TABLE 487            MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET

FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)            325

TABLE 488            MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               326

TABLE 489            MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               326

TABLE 490            REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               327

TABLE 491            REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 327

TABLE 492            REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)            327

TABLE 493            REST OF LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         328

TABLE 494            REST OF LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET

FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)                 328

TABLE 495            REST OF LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         329

TABLE 496            REST OF LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET

FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)            329

TABLE 497            REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 329

TABLE 498            REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       330

TABLE 499            REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET

FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)            330

TABLE 500            REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)       330

TABLE 501            REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)       331

TABLE 502            MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               331

TABLE 503            MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         332

TABLE 504            MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          332

TABLE 505            MIDDLE EAST: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         332

TABLE 506            MIDDLE EAST: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET

FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)                 333

TABLE 507            MIDDLE EAST: SPATIAL GENOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         333

TABLE 508            MIDDLE EAST: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)            333

TABLE 509            MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         334

TABLE 510            MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       334

TABLE 511            MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)         334

TABLE 512            MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               335

TABLE 513            MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               335

TABLE 514            MIDDLE EAST: KEY MACROINDICATORS                 336

TABLE 515            AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               337

TABLE 516            AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         337

TABLE 517            AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          337

TABLE 518            AFRICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         338

TABLE 519            AFRICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET

FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)                 338

TABLE 520            AFRICA: SPATIAL GENOMICS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         339

TABLE 521            AFRICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,

BY TYPE, 2022–2029 (USD MILLION)         339

TABLE 522            AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         339

TABLE 523            AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       340

TABLE 524            AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET

FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)            340

TABLE 525            AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               340

TABLE 526            AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               341

TABLE 527            AFRICA: KEY MACROINDICATORS            342

TABLE 528            STRATEGIES ADOPTED BY KEY PLAYERS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, 2021−2024                 344

TABLE 529            SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET:

DEGREE OF COMPETITION         350

TABLE 530            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: REGION FOOTPRINT 358

TABLE 531            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: OFFERING FOOTPRINT             359

TABLE 532            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: TECHNIQUE FOOTPRINT         360

TABLE 533            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: APPLICATION FOOTPRINT     361

TABLE 534            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: KEY STARTUPS/SMES 364

TABLE 535            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES              365

TABLE 536            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET:

PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 366

TABLE 537            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET:

DEALS, JANUARY 2021–NOVEMBER 2024                 367

TABLE 538            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET:

EXPANSIONS, JANUARY 2021–NOVEMBER 2024    368

TABLE 539            10X GENOMICS: COMPANY OVERVIEW  369

TABLE 540            10X GENOMICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED    371

TABLE 541            10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024                 372

TABLE 542            10X GENOMICS: DEALS, JANUARY 2021–NOVEMBER 2024               373

TABLE 543            10X GENOMICS: EXPANSIONS, JANUARY 2021–NOVEMBER 2024               373

TABLE 544            BIO-TECHNE: COMPANY OVERVIEW      375

TABLE 545            BIO-TECHNE: PRODUCTS/SERVICES/SOLUTIONS OFFERED    376

TABLE 546            BIO-TECHNE: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024    378

TABLE 547            BIO-TECHNE: DEALS, JANUARY 2021–NOVEMBER 2024               379

TABLE 548            BIO-TECHNE: EXPANSIONS, JANUARY 2021–NOVEMBER 2024               379

TABLE 549            NANOSTRING TECHNOLOGIES, INC. (BRUKER SPATIAL BIOLOGY, INC.):

COMPANY OVERVIEW   381

TABLE 550            NANOSTRING TECHNOLOGIES, INC. (BRUKER SPATIAL BIOLOGY, INC.): PRODUCTS/SERVICES/SOLUTIONS OFFERED             383

TABLE 551            NANOSTRING TECHNOLOGIES, INC. (BRUKER SPATIAL BIOLOGY, INC.):

PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 384

TABLE 552            NANOSTRING TECHNOLOGIES, INC. (BRUKER SPATIAL BIOLOGY, INC.):

DEALS, JANUARY 2021–NOVEMBER 2024                 385

TABLE 553            STANDARD BIOTOOLS: COMPANY OVERVIEW                 387

TABLE 554            STANDARD BIOTOOLS: PRODUCTS/SERVICES/SOLUTIONS OFFERED    389

TABLE 555            STANDARD BIOTOOLS: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024                 391

TABLE 556            STANDARD BIOTOOLS: DEALS, JANUARY 2021–NOVEMBER 2024               391

TABLE 557            ILLUMINA, INC.: COMPANY OVERVIEW 393

TABLE 558            ILLUMINA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    395

TABLE 559            ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024                 396

TABLE 560            ILLUMINA, INC.: DEALS, JANUARY 2021–NOVEMBER 2024               396

TABLE 561            BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW          398

TABLE 562            BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    399

TABLE 563            BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES,

JANUARY 2021–NOVEMBER 2024                 400

TABLE 564            BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021–NOVEMBER 2024                 400

TABLE 565            AKOYA BIOSCIENCES, INC.: COMPANY OVERVIEW          401

TABLE 566            AKOYA BIOSCIENCES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    402

TABLE 567            AKOYA BIOSCIENCES, INC.: PRODUCT LAUNCHES,

JANUARY 2021–NOVEMBER 2024                 402

TABLE 568            AKOYA BIOSCIENCES, INC.: DEALS, JANUARY 2021–NOVEMBER 2024    403

TABLE 569            AKOYA BIOSCIENCES, INC.: EXPANSIONS, JANUARY 2021–NOVEMBER 2024                 404

TABLE 570            VISIOPHARM A/S: COMPANY OVERVIEW                 405

TABLE 571            VISIOPHARM A/S: PRODUCTS/SERVICES/SOLUTIONS OFFERED    405

TABLE 572            VISIOPHARM A/S: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024                 406

TABLE 573            VISIOPHARM A/S: DEALS, JANUARY 2021–NOVEMBER 2024               406

TABLE 574            DANAHER CORPORATION: COMPANY OVERVIEW          407

TABLE 575            DANAHER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED    409

TABLE 576            DANAHER CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024    409

TABLE 577            SEVEN BRIDGES GENOMICS: COMPANY OVERVIEW          410

TABLE 578            SEVEN BRIDGES GENOMICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED    410

TABLE 579            SEVEN BRIDGES GENOMICS: DEALS, JANUARY 2021–NOVEMBER 2024    411

TABLE 580            REVVITY: COMPANY OVERVIEW               412

TABLE 581            REVVITY: PRODUCTS/SERVICES/SOLUTIONS OFFERED             414

TABLE 582            REVVITY: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–NOVEMBER 2024                 414

TABLE 583            REVVITY: DEALS, JANUARY 2021–NOVEMBER 2024        415

TABLE 584            VIZGEN INC.: COMPANY OVERVIEW       416

TABLE 585            VIZGEN INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    416

TABLE 586            VIZGEN INC.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024    417

TABLE 587            VIZGEN INC.: DEALS, JANUARY 2021–NOVEMBER 2024        418

TABLE 588            VERACYTE, INC.: COMPANY OVERVIEW 419

TABLE 589            VERACYTE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    419

TABLE 590            NATERA, INC.: COMPANY OVERVIEW     420

TABLE 591            NATERA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    422

TABLE 592            NATERA, INC.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024    422

TABLE 593            NATERA, INC.: EXPANSIONS, JANUARY 2021–NOVEMBER 2024               423

TABLE 594            MACROGEN INC.: COMPANY OVERVIEW                 424

TABLE 595            MACROGEN INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    425

TABLE 596            MACROGEN, INC.: DEALS, JANUARY 2021–NOVEMBER 2024               425

TABLE 597            MILTENYI BIOTEC: COMPANY OVERVIEW                 426

TABLE 598            MILTENYI BIOTEC: PRODUCTS/SERVICES/SOLUTIONS OFFERED    426

TABLE 599            MILTENYI BIOTEC: DEALS, JANUARY 2021–NOVEMBER 2024               427

TABLE 600            BIOMARKER TECHNOLOGIES (BMKGENE): COMPANY OVERVIEW   428

TABLE 601            ULTIVUE, INC: COMPANY OVERVIEW    429

TABLE 602            RARECYTE, INC.: COMPANY OVERVIEW 430

TABLE 603            S2 GENOMICS, INC.: COMPANY OVERVIEW                 431

TABLE 604            ADMERA HEALTH: COMPANY OVERVIEW                 432

TABLE 605            SONY BIOTECHNOLOGY INC.: COMPANY OVERVIEW          433

TABLE 606            CANTATA BIO: COMPANY OVERVIEW    434

TABLE 607            NUCLEAI, INC.: COMPANY OVERVIEW   435

TABLE 608            VISIKOL, INC.: COMPANY OVERVIEW     436

TABLE 609            IONPATH, INC.: COMPANY OVERVIEW  437

TABLE 610            BIOSPYDER, INC.: COMPANY OVERVIEW                 438

TABLE 611            SINGULAR GENOMICS SYSTEMS, INC.: COMPANY OVERVIEW   439

TABLE 612            LUNAPHORE TECHNOLOGIES SA.: COMPANY OVERVIEW          440

TABLE 613            REBUS BIOSYSTEMS, INC.: COMPANY OVERVIEW          441

LIST OF FIGURES

FIGURE 1              SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: SEGMENTS

AND REGIONS CONSIDERED      43

FIGURE 2              SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: YEARS CONSIDERED  44

FIGURE 3              SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: RESEARCH DESIGN     46

FIGURE 4              BREAKDOWN OF PRIMARIES: BY RESPONDENT, DESIGNATION, AND REGION     48

FIGURE 5              SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023                 49

FIGURE 6              SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023        49

FIGURE 7              MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2023 (PRODUCTS MARKET)             50

FIGURE 8              SERVICES MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (2023)                 51

FIGURE 9              PRODUCTS MARKET REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF ILLUMINA, INC. (2023)                 51

FIGURE 10            MARKET SIZE VALIDATION FROM PRIMARIES                 53

FIGURE 11            MARKET SIZE ESTIMATION: TOP-DOWN APPROACH (PRODUCT)                53

FIGURE 12            SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET:

CAGR PROJECTIONS (2024–2029)                55

FIGURE 13            SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET:

CAGR PROJECTIONS (2024–2029)                55

FIGURE 14            SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET:

DATA TRIANGULATION                57

FIGURE 15            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY OFFERING, 2024 VS. 2029 (USD MILLION)        60

FIGURE 16            SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY TECHNIQUE, 2024 VS. 2029 (USD MILLION)    61

FIGURE 17            SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY TYPE, 2024 VS. 2029 (USD MILLION)  61

FIGURE 18            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,

BY APPLICATION, 2024 VS. 2029 (USD MILLION) 62

FIGURE 19            SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,

BY END USER, 2024 VS. 2029 (USD MILLION)        62

FIGURE 20            SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,

BY END USER, 2024 VS. 2029 (USD MILLION)        63

FIGURE 21            SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET:

REGIONAL SNAPSHOT  64

FIGURE 22            HIGH R&D INVESTMENTS AND INCREASED FOCUS ON DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET               65

FIGURE 23            CHINA AND SPATIAL TRANSCRIPTOMICS COMMANDED LARGEST

MARKET SHARE IN 2023 66

FIGURE 24            CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD         67

FIGURE 25            ACADEMIC & RESEARCH INSTITUTES ACCOUNTED FOR LARGEST SHARE IN SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET 2023   68

FIGURE 26            ACADEMIC & RESEARCH INSTITUTES ACCOUNTED FOR LARGEST SHARE IN SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET IN 2023 68

FIGURE 27            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    69

FIGURE 28            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: TRENDS/ DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS            75

FIGURE 29            AVERAGE SELLING PRICE TREND OF INSTRUMENTS,

BY KEY PLAYER, 2021–2023 (USD)              76

FIGURE 30            AVERAGE SELLING PRICE TREND OF CONSUMABLES,

BY KEY PLAYER, 2021–2023 (USD)              77

FIGURE 31            AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2023 (USD) 78

FIGURE 32            AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2022 (USD) 79

FIGURE 33            AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2021 (USD) 80

FIGURE 34            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: SUPPLY CHAIN ANALYSIS         81

FIGURE 35            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: VALUE CHAIN ANALYSIS           82

FIGURE 36            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: ECOSYSTEM ANALYSIS              84

FIGURE 37            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: NUMBER OF PATENT APPLICANTS/OWNERS IN LAST 10 YEARS (2014–2024)       88

FIGURE 38            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET:

PORTER’S FIVE FORCES ANALYSIS           95

FIGURE 39            INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING              97

FIGURE 40            KEY BUYING CRITERIA, BY END USER (PRODUCT)        98

FIGURE 41            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: INVESTMENT & FUNDING SCENARIO, 2021–2023 (USD MILLION)            101

FIGURE 42            IMPACT OF AI/GEN AI ON SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET 102

FIGURE 43            NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SNAPSHOT              227

FIGURE 44            ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SNAPSHOT              277

FIGURE 45            REVENUE ANALYSIS OF KEY PLAYERS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, 2019−2023                 348

FIGURE 46            MARKET SHARE ANALYSIS OF SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, 2023                 349

FIGURE 47            RANKING OF KEY PLAYERS IN SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, 2023                 351

FIGURE 48            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF

KEY VENDORS  352

FIGURE 49            EV/EBITDA OF KEY PLAYERS      352

FIGURE 50            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 353

FIGURE 51            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023                 356

FIGURE 52            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY FOOTPRINT             357

FIGURE 53            SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023        363

FIGURE 54            10X GENOMICS: COMPANY SNAPSHOT  370

FIGURE 55            BIO-TECHNE: COMPANY SNAPSHOT      376

FIGURE 56            NANOSTRING TECHNOLOGIES, INC. (BRUKER SPATIAL BIOLOGY, INC.):

COMPANY SNAPSHOT   382

FIGURE 57            STANDARD BIOTOOLS: COMPANY SNAPSHOT                 388

FIGURE 58            ILLUMINA, INC.: COMPANY SNAPSHOT 394

FIGURE 59            BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT          399

FIGURE 60            AKOYA BIOSCIENCES, INC.: COMPANY SNAPSHOT          401

FIGURE 61            DANAHER CORPORATION: COMPANY SNAPSHOT          408

FIGURE 62            REVVITY: COMPANY SNAPSHOT               413

FIGURE 63            NATERA, INC.: COMPANY SNAPSHOT     421

FIGURE 64            MACROGEN INC.: COMPANY SNAPSHOT                 424

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧